Furthermore, our immunohistochemical data demonstrates that IL-33+ syngeneic glioma, and IL-33+ xenografts associate with an increase in Iba1+ cells in the tumor-bearing hemisphere (Fig. 3 and Supplementary Fig. 3). The gene discussed is IL33; the disease is central nervous system cancer.